Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar;84(3):e31-e33.
doi: 10.1016/j.jinf.2022.01.022. Epub 2022 Jan 21.

A meta-analysis of the association between calprotectin and the severity of COVID-19

Qin Mao  1 , Chunyi Wang  1 , Wen Wen  1 , Mengyun Zhou  2 , Jiake Tang  1 , Chen Chen  1 , Yongran Cheng  3 , Qi Wu  1 , Xingwei Zhang  1 , Zhanhui Feng  4 , Mingwei Wang  5
Affiliations
Comment

A meta-analysis of the association between calprotectin and the severity of COVID-19

Qin Mao et al. J Infect. 2022 Mar.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Forest plot (FEM) comparing the mean differences in calprotectin level between severe and non-severe COVID-19.
See this image and copyright information in PMC

Comment on

References

    1. Mentzer A.J., James T., Yongya M., Cox S., Paddon K., Shine B., et al. Serum calprotectin is not an independent predictor of severe COVID-19 in ambulatory adult patients. J Infect. 2021 Nov 27;S0163-4453(21):00580–00586. doi: 10.1016/j.jinf.2021.11.017. - DOI - PMC - PubMed
    1. Lee A., Nahm C.H., Lee J.S., Lee M.K., Lee K.R. Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19. J Clin Lab Anal. 2021;35(11):e24004. doi: 10.1002/jcla.24004. Nov. - DOI - PMC - PubMed
    1. Udeh R., Advani S., de Guadiana Romualdo L.G., Dolja-Gore X. Calprotectin, an Emerging Biomarker of Interest in COVID-19: a Systematic Review and Meta-Analysis. J Clin Med. 2021 Feb 15;10(4):775. doi: 10.3390/jcm10040775. - DOI - PMC - PubMed
    1. Cherubini F., Cristiano A., Valentini A., Bernardini S., Nuccetelli M. Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study. Inflamm Res. 2021;70(6):687–694. doi: 10.1007/s00011-021-01465-y. Jun. - DOI - PMC - PubMed
    1. Ducastel M., Chenevier-Gobeaux C., Ballaa Y., Meritet J.F., Brack M., Chapuis N., et al. Oxidative Stress and Inflammatory Biomarkers for the Prediction of Severity and ICU Admission in Unselected Patients Hospitalized with COVID-19. Int J Mol Sci. 2021 Jul 12;22(14):7462. doi: 10.3390/ijms22147462. - DOI - PMC - PubMed

Substances